Shafaqna English- A new study suggests that blockbuster GLP-1 drugs, such as Ozempic and Wegovy may do more than treat diabetes and obesity; they could also help combat drug and alcohol addiction. These medications appear to act on brain circuits involved in reward and craving, potentially reducing addictive behaviors.
Early research, including trials in humans, has shown promising results. Studies indicate that GLP-1 drugs can reduce alcohol consumption, curb the urge for opioids, and lessen nicotine use. This offers hope for a new treatment avenue, as current options for addiction are limited and fall short of public health needs.
While scientists are optimistic, they caution that more research is needed to confirm these effects and understand how they work. However, the potential is significant, as these medications could address the critical need for more effective tools against substance use disorders.
Source: The Endocrine Society